The 11th annual Utah Life Sciences Summit (ULSS) Nov. 9-11, went virtual this year. But despite the physical distance, the ULSS made news and ignited our life sciences industry with a special announcement — the launch of BioHive, a new bold campaign to brand and expand Utah’s life sciences ecosystem. ICYMI…view the video and see […]
Transit Scientific’s new FDA cleared XO Score system was successfully used to dilate multiple challenging fibrotic and calcific lesions in hemodialysis patients with stenotic and occluded fistulas. Dr. Richard Saxon, FSIR and member of the SDI Medical Group, while working at Tri City Medical Center Medical Center, Oceanside, California, USA performed the first procedures using […]
Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement Medal for Science and Technology for his contribution in the field of biotechnology and pharmaceuticals. “This honor is well-deserved,” said Kelvyn Cullimore, president and CEO of BioUtah. “Dr. Patel has been instrumental in founding and bringing a […]
Sanofi and the Parkinson’s Foundation announced on Wednesday a new research collaboration to advance the availability of genetic testing and counseling for people with Parkinson’s disease in the U.S. Over the next two years, Sanofi will provide $1 million in research funding to support the PD GENEration Mapping the Future of Parkinson’s Disease initiative. The […]
On October 7, the SBA released updated FAQs (question #52) to clarify that lenders must recognize the extended deferral period for payments on the principal, interest, and fees on all PPP loans, even if the initial loan terms indicates a six-month deferral (the initial period when the program was first enacted). Under the Paycheck Protection […]
Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse of antimicrobial drugs, IDbyDNA and Illumina, Inc. are co-launching the new Respiratory Pathogen ID/AMR Target Enrichment Assay. The test, currently for research use only, will improve testing for infectious diseases, including COVID-19, and will leverage IDbyDNA’s Explify® […]
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the PKM2 activator, TP-1454, in a Phase 1/1b study in patients with advanced metastatic or progressive solid tumors. “Dosing the first patient in this study marks an important milestone, as TP-1454 is the first PKM2 activator to be […]
On Wednesday, Governor Herbert announced the state’s new response plan to COVID-19, effective October 15. This updated plan utilizes a COVID-19 Transmission Index and replaces the previous color-coded guidance system of red, orange, yellow and green. The new approach comes at a time when the state has seen a significant spike in infection rates. The […]
Congress recently provided a short-term extension until December 11 of the Rare Pediatric Disease Priority Review Voucher program. The program was set to expire on September 30, but was given a reprieve in the Continuing Appropriations Act, 2021 and Other Extensions Act (H.R. 8337) that kept the government funded. Congress will have to act again […]
On Tuesday, SINTX Technologies (SINTX) announced progress toward the manufacture of a “catch-and-kill” mask that will inactivate respiratory viruses. SINTX has successfully embedded silicon nitride particles into nonwoven and woven fabric fibers. Silicon nitride has been shown to neutralize several bacterial species and viral strains, including SARS-CoV-2. “By investing in our human resources and equipment, […]
Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical device company that has developed the XenoscopeTM, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed to be fog proof, the Xenoscope minimizes common visualization challenges and provides consistent image quality through electrocautery smoke. MPVF’s […]
Johnson & Johnson recently announced that it’s joined 15 other companies in signing a Communiquie on Expanded Global Access to ensure that people everywhere – regardless of their income level – have access to COVID-19 vaccines, therapeutics and diagnostics under development at these companies. Each of the signing companies—AstraZeneca; Bayer; bioMérieux; Boehringer Ingelheim; Bristol Myers […]